Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: Possible implications in idiopathic pulmonary fibrosis

American Journal of Pathology

Volumn 185, Issue 4, 2015, Pages 943-957

  Kirillov, Varvara ^a   Siler, Jonathan T ^a   Ramadass, Mahalakshmi ^a   Ge, Lingyin ^a   Davis, James ^a   Grant, Geraldine ^b   Nathan, Steven D ^c   Jarai, Gabor ^d   Trujillo, Glenda ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c INOVA FAIRFAX HOSPITAL   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MATRIX METALLOPROTEINASE 14; TOLL LIKE RECEPTOR 9; CPG-OLIGONUCLEOTIDE; OLIGODEOXYRIBONUCLEOTIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR AB; TLR9 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ACTIVATION; CELL CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG PARENCHYMA; LUNG TRANSPLANTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; UPREGULATION; VIRUS INFECTION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; CASE CONTROL STUDY; CELL HYPOXIA; DRUG EFFECTS; ENZYMOLOGY; LUNG; METABOLISM; MOUSE; MYOFIBROBLAST; PATHOLOGY;

ANIMALS; APOPTOSIS; CASE-CONTROL STUDIES; CELL HYPOXIA; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MATRIX METALLOPROTEINASE 14; MICE; MYOFIBROBLASTS; OLIGODEOXYRIBONUCLEOTIDES; PHENOTYPE; PLATELET-DERIVED GROWTH FACTOR; TOLL-LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925340645     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.12.011     Document Type: Article

References (80)

1. T.S. Blackwell, A.M. Tager, Z. Borok, B.B. Moore, D.A. Schwartz, and K.J. Anstrom Future directions in idiopathic pulmonary fibrosis research: an NHLBI workshop report Am J Respir Crit Care Med 189 2014 214 222
2. I.E. Fernandez, and O. Eickelberg The impact of TGF-beta on lung fibrosis: from targeting to biomarkers Proc Am Thorac Soc 9 2012 111 116
3. B. Moore, W.E. Lawson, T.D. Oury, T.H. Sisson, K. Raghavendran, and C.M. Hogaboam Animal models of fibrotic lung disease Am J Respir Cell Mol Biol 49 2013 167 179
4. S.C. Wootton, D.S. Kim, Y. Kondoh, E. Chen, J.S. Lee, J.W. Song, J.W. Huh, H. Taniguchi, C. Chiu, H. Boushey, L.H. Lancaster, P.J. Wolters, J. DeRisi, D. Ganem, and H.R. Collard Viral infection in acute exacerbation of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 183 2011 1698 1702
5. H.R. Collard, B.B. Moore, K.R. Flaherty, K.K. Brown, R.J. Kaner, T.E. King Jr., J.A. Lasky, J.E. Loyd, I. Noth, M.A. Olman, G. Raghu, J. Roman, J.H. Ryu, D.A. Zisman, G.W. Hunninghake, T.V. Colby, J.J. Egan, D.M. Hansell, T. Johkoh, N. Kaminski, D.S. Kim, Y. Kondoh, D.A. Lynch, J. Muller-Quernheim, J.L. Myers, A.G. Nicholson, M. Selman, G.B. Toews, A.U. Wells, and F.J. Martinez Acute exacerbations of idiopathic pulmonary fibrosis Am J Respir Crit Care Med 176 2007 636 643
6. M. Selman, G. Carrillo, A. Estrada, M. Mejia, C. Becerril, J. Cisneros, M. Gaxiola, R. Perez-Padilla, C. Navarro, T. Richards, J. Dauber, T.E. King Jr., A. Pardo, and N. Kaminski Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern PLoS One 2 2007 e482
7. C.M. Hogaboam, G. Trujillo, and F.J. Martinez Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis Fibrogenesis Tissue Repair 5 Suppl 1 2012 S3
8. G. Trujillo, A. Meneghin, K.R. Flaherty, L.M. Sholl, J.L. Myers, E.A. Kazerooni, B.H. Gross, S.R. Oak, A.L. Coelho, H. Evanoff, E. Day, G.B. Toews, A.D. Joshi, M.A. Schaller, B. Waters, G. Jarai, J. Westwick, S.L. Kunkel, F.J. Martinez, and C.M. Hogaboam TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis Sci Transl Med 2 2010 57ra82
9. C.K. Holm, S.R. Paludan, and K.A. Fitzgerald DNA recognition in immunity and disease Curr Opin Immunol 25 2013 13 18
10. J.P. Stewart, J.J. Egan, A.J. Ross, B.G. Kelly, S.S. Lok, P.S. Hasleton, and A.A. Woodcock The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 159 1999 1336 1341
11. Y.W. Tang, J.E. Johnson, P.J. Browning, R.A. Cruz-Gervis, A. Davis, B.S. Graham, K.L. Brigham, J.A. Oates Jr., J.E. Loyd, and A.A. Stecenko Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis J Clin Microbiol 41 2003 2633 2640
12. F. Calabrese, A. Kipar, F. Lunardi, E. Balestro, E. Perissinotto, E. Rossi, N. Nannini, G. Marulli, J.P. Stewart, and F. Rea Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis PLoS One 8 2013 e55715
13. S. Guggemoos, D. Hangel, S. Hamm, A. Heit, S. Bauer, and H. Adler TLR9 contributes to antiviral immunity during gammaherpesvirus infection J Immunol 180 2008 438 443
14. L. Zauner, and D. Nadal Understanding TLR9 action in Epstein-Barr virus infection Front Biosci (Landmark Ed) 17 2012 1219 1231
15. V.A. Folcik, M. Garofalo, J. Coleman, J.J. Donegan, E. Rabbani, S. Suster, A. Nuovo, C.M. Magro, G. Di Leva, and G.J. Nuovo Idiopathic pulmonary fibrosis is strongly associated with productive infection by herpesvirus saimiri Mod Pathol 27 2014 851 862
16. T.A. Wynn Cellular and molecular mechanisms of fibrosis J Pathol 214 2008 199 210
17. C.D. Ellson, R. Dunmore, C.M. Hogaboam, M.A. Sleeman, and L.A. Murray Danger-associated molecular patterns and danger signals in IPF Am J Respir Cell Mol Biol 51 2014 163 168
18. D. Droemann, D. Albrecht, J. Gerdes, A.J. Ulmer, D. Branscheid, E. Vollmer, K. Dalhoff, P. Zabel, and T. Goldmann Human lung cancer cells express functionally active Toll-like receptor 9 Respir Res 6 2005 1
19. C. Vancheri Common pathways in idiopathic pulmonary fibrosis and cancer Eur Respir Rev 22 2013 265 272
20. Y. Li, D. Jiang, J. Liang, E.B. Meltzer, A. Gray, R. Miura, L. Wogensen, Y. Yamaguchi, and P.W. Noble Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44 J Exp Med 208 2011 1459 1471
21. C. Vancheri Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology Proc Am Thorac Soc 9 2012 153 157
22. M.C. Bruce, and C.E. Honaker Transcriptional regulation of tropoelastin expression in rat lung fibroblasts: changes with age and hyperoxia Am J Physiol 274 1998 L940 L950
23. J. Wang, H. Chen, A. Seth, and C.A. McCulloch Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts Am J Physiol Heart Circ Physiol 285 2003 H1871 H1881
24. B. Chailley-Heu, O. Boucherat, A.M. Barlier-Mur, and J.R. Bourbon FGF-18 is upregulated in the postnatal rat lung and enhances elastogenesis in myofibroblasts Am J Physiol Lung Cell Mol Physiol 288 2005 L43 L51
25. O. Boucherat, M.L. Franco-Montoya, C. Thibault, R. Incitti, B. Chailley-Heu, C. Delacourt, and J.R. Bourbon Gene expression profiling in lung fibroblasts reveals new players in alveolarization Physiol Genomics 32 2007 128 141
26. M.C. Emblom-Callahan, M.K. Chhina, O.A. Shlobin, S. Ahmad, E.S. Reese, E.P. Iyer, D.N. Cox, R. Brenner, N.A. Burton, G.M. Grant, and S.D. Nathan Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis Genomics 96 2010 134 145
27. S. Yang, H. Cui, N. Xie, M. Icyuz, S. Banerjee, V.B. Antony, E. Abraham, V.J. Thannickal, and G. Liu miR-145 regulates myofibroblast differentiation and lung fibrosis FASEB J 27 2013 2382 2391
28. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira A Toll-like receptor recognizes bacterial DNA Nature 408 2000 740 745
29. E. Latz, A. Schoenemeyer, A. Visintin, K.A. Fitzgerald, B.G. Monks, C.F. Knetter, E. Lien, N.J. Nilsen, T. Espevik, and D.T. Golenbock TLR9 signals after translocating from the ER to CpG DNA in the lysosome Nat Immunol 5 2004 190 198
30. Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki, and C.J. Hauser Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 464 2010 104 107
31. T. Oka, S. Hikoso, O. Yamaguchi, M. Taneike, T. Takeda, T. Tamai, J. Oyabu, T. Murakawa, H. Nakayama, K. Nishida, S. Akira, A. Yamamoto, I. Komuro, and K. Otsu Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure Nature 485 2012 251 255
32. A. Meneghin, E.S. Choi, H.L. Evanoff, S.L. Kunkel, F.J. Martinez, K.R. Flaherty, G.B. Toews, and C.M. Hogaboam TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation Histochem Cell Biol 130 2008 979 992
33. L. Hecker, R. Jagirdar, T. Jin, and V.J. Thannickal Reversible differentiation of myofibroblasts by MyoD Exp Cell Res 317 2011 1914 1921
34. S. Prasad, C.M. Hogaboam, and G. Jarai Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair Fibrogenesis Tissue Repair 7 2014 7
35. H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature 370 1994 61 65
36. A. Kuznik, M. Bencina, U. Svajger, M. Jeras, B. Rozman, and R. Jerala Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines J Immunol 186 2011 4794 4804
37. M. Rutz, J. Metzger, T. Gellert, P. Luppa, G.B. Lipford, H. Wagner, and S. Bauer Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence-and pH-dependent manner Eur J Immunol 34 2004 2541 2550
38. M.A. Sanjuan, N. Rao, K.T. Lai, Y. Gu, S. Sun, A. Fuchs, W.P. Fung-Leung, M. Colonna, and L. Karlsson CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion J Cell Biol 172 2006 1057 1068
39. W. Bechtel, and M. Zeisberg Twist: a new link from hypoxia to fibrosis Kidney Int 75 2009 1255 1256
40. S. Chettimada, S.R. Joshi, A. Alzoubi, S.A. Gebb, I.F. McMurtry, R. Gupte, and S.A. Gupte Glucose-6-phosphate dehydrogenase plays a critical role in hypoxia-induced CD133+ progenitor cells self-renewal and stimulates their accumulation in the lungs of pulmonary hypertensive rats Am J Physiol Lung Cell Mol Physiol 307 2014 L545 L556
41. D.F. Higgins, K. Kimura, W.M. Bernhardt, N. Shrimanker, Y. Akai, B. Hohenstein, Y. Saito, R.S. Johnson, M. Kretzler, C.D. Cohen, K.-U. Eckardt, M. Iwano, and V.H. Haase Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition J Clin Invest 117 2007 3810 3820
42. B. Eul, F. Rose, S. Krick, R. Savai, P. Goyal, W. Klepetko, F. Grimminger, N. Weissmann, W. Seeger, and J. Hänze Impact of HIF-1alpha and HIF-2alpha on proliferation and migration of human pulmonary artery fibroblasts in hypoxia FASEB J 20 2006 163 165
43. A. Ahmad, S. Ahmad, K.C. Malcolm, S.M. Miller, T. Hendry-Hofer, J.B. Schaack, and C.W. White Differential regulation of pulmonary vascular cell growth by hypoxia-inducible transcription factor-1alpha and hypoxia-inducible transcription factor-2alpha Am J Respir Cell Mol Biol 49 2013 78 85
44. L. Holmquist-Mengelbier, E. Fredlund, T. Löfstedt, R. Noguera, S. Navarro, H. Nilsson, A. Pietras, J. Vallon-Christersson, A. Borg, K. Gradin, L. Poellinger, and S. Påhlman Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype Cancer Cell 10 2006 413 423
45. J.K. Maranchie, J.R. Vasselli, J. Riss, J.S. Bonifacino, W.M. Linehan, and R.D. Klausner The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma Cancer Cell 1 2002 247 255
46. K. Kondo, W.Y. Kim, M. Lechpammer, and W.G. Kaelin Jr. Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth PLoS Biol 1 2003 E83
47. K. Kondo, J. Klco, E. Nakamura, M. Lechpammer, and W.G. Kaelin Jr. Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein Cancer Cell 1 2002 237 246
48. E.B. Rankin, J. Rha, T.L. Unger, C.H. Wu, H.P. Shutt, R.S. Johnson, M.C. Simon, B. Keith, and V.H. Haase Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice Oncogene 27 2008 5354 5358
49. R. Malhotra, Z. Lin, C. Vincenz, and F.C. Brosius III Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose Am J Physiol Cell Physiol 281 2001 C1596 C1603
50. A. Todor, V.G. Sharov, E.J. Tanhehco, N. Silverman, A. Bernabei, and H.N. Sabbah Hypoxia-induced cleavage of caspase-3 and DFF45/ICAD in human failed cardiomyocytes Am J Physiol Heart Circ Physiol 283 2002 H990 H995
51. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 2002 161 174
52. K. Zarrabi, A. Dufour, J. Li, C. Kuscu, A. Pulkoski-Gross, J. Zhi, Y. Hu, N.S. Sampson, S. Zucker, and J. Cao Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration J Biol Chem 286 2011 33167 33177
53. J. Garcia-Alvarez, R. Ramirez, C.L. Sampieri, R.K. Nuttall, D.R. Edwards, M. Selman, and A. Pardo Membrane type-matrix metalloproteinases in idiopathic pulmonary fibrosis Sarcoidosis Vasc Diffuse Lung Dis 23 2006 13 21
54. M. Selman, V. Ruiz, S. Cabrera, L. Segura, R. Ramirez, R. Barrios, and A. Pardo TIMP-1,-2,-3, and-4 in idiopathic pulmonary fibrosis: a prevailing nondegradative lung microenvironment' Am J Physiol Lung Cell Mol Physiol 279 2000 L562 L574
55. R.G. Rowe, D. Keena, F. Sabeh, A.L. Willis, and S.J. Weiss Pulmonary fibroblasts mobilize the membrane-tethered matrix metalloprotease, MT1-MMP, to destructively remodel and invade interstitial type I collagen barriers Am J Physiol 301 2011 L683 L692
56. C.M. Hogaboam, L. Murray, and F.J. Martinez Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression Proc Am Thorac Soc 9 2012 172 176
57. H. Suganuma, A. Sato, R. Tamura, and K. Chida Enhanced migration of fibroblasts derived from lungs with fibrotic lesions Thorax 50 1995 984 989
58. E.S. White, V.J. Thannickal, S.L. Carskadon, E.G. Dickie, D.L. Livant, S. Markwart, G.B. Toews, and D.A. Arenberg Integrin alpha4beta1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10 Am J Respir Crit Care Med 168 2003 436 442
59. A. Pardo, and M. Selman Matrix metalloproteases in aberrant fibrotic tissue remodeling Proc Am Thorac Soc 3 2006 383 388
60. M.A. Merrell, J.M. Ilvesaro, N. Lehtonen, T. Sorsa, B. Gehrs, E. Rosenthal, D. Chen, B. Shackley, K.W. Harris, and K.S. Selander Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity Mol Cancer Res 4 2006 437 447
61. E.J. Lim, S.H. Lee, J.G. Lee, J.R. Kim, S.S. Yun, S.H. Baek, and C. Lee Toll-like receptor 9 dependent activation of MAPK and NF-kB is required for the CpG ODN-induced matrix metalloproteinase-9 expression Exp Mol Med 39 2007 239 245
62. J.M. Ilvesaro, M.A. Merrell, T.M. Swain, J. Davidson, M. Zayzafoon, K.W. Harris, and K.S. Selander Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro Prostate 67 2007 774 781
63. J.M. Ilvesaro, M.A. Merrell, L. Li, S. Wakchoure, D. Graves, S. Brooks, E. Rahko, A. Jukkola-Vuorinen, K.S. Vuopala, K.W. Harris, and K.S. Selander Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion Mol Cancer Res 6 2008 1534 1543
64. A. Pardo, K. Gibson, J. Cisneros, T.J. Richards, Y. Yang, C. Becerril, S. Yousem, I. Herrera, V. Ruiz, M. Selman, and N. Kaminski Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis PLoS Med 2 2005 e251
65. G.F. Weber, S. Ashkar, M.J. Glimcher, and H. Cantor Receptor-ligand interaction between CD44 and osteopontin (Eta-1) Science 271 1996 509 512
66. D.T. Denhardt, M. Noda, A.W. O'Regan, D. Pavlin, and J.S. Berman Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival J Clin Invest 107 2001 1055 1061
67. A. O'Regan, and J.S. Berman Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation Int J Exp Pathol 81 2000 373 390
68. F. Takahashi, K. Takahashi, T. Okazaki, K. Maeda, H. Ienaga, M. Maeda, S. Kon, T. Uede, and Y. Fukuchi Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis Am J Respir Cell Mol Biol 24 2001 264 271
69. V.J. Thannickal, and J.C. Horowitz Evolving concepts of apoptosis in idiopathic pulmonary fibrosis Proc Am Thorac Soc 3 2006 350 356
70. A. Tzouvelekis, V. Harokopos, T. Paparountas, N. Oikonomou, A. Chatziioannou, G. Vilaras, E. Tsiambas, A. Karameris, D. Bouros, and V. Aidinis Comparative expression profiling in pulmonary fibrosis suggests a role of hypoxia-inducible factor-1alpha in disease pathogenesis Am J Respir Crit Care Med 176 2007 1108 1119
71. C.M. Robinson, R. Neary, A. Levendale, C.J. Watson, and J.A. Baugh Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype Respir Res 13 2012 74
72. S.E. Ewald, B.L. Lee, L. Lau, K.E. Wickliffe, G.P. Shi, H.A. Chapman, and G.M. Barton The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor Nature 456 2008 658 662
73. B. Park, M.M. Brinkmann, E. Spooner, C.C. Lee, Y.M. Kim, and H.L. Ploegh Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 Nat Immunol 9 2008 1407 1414
74. F. Matsumoto, S. Saitoh, R. Fukui, T. Kobayashi, N. Tanimura, K. Konno, Y. Kusumoto, S. Akashi-Takamura, and K. Miyake Cathepsins are required for Toll-like receptor 9 responses Biochem Biophys Res Commun 367 2008 693 699
75. K. Yasuda, C. Richez, M.B. Uccellini, R.J. Richards, R.G. Bonegio, S. Akira, M. Monestier, R.B. Corley, G.A. Viglianti, A. Marshak-Rothstein, and I.R. Rifkin Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes J Immunol 183 2009 3109 3117
76. T.K. Means, E. Latz, F. Hayashi, M.R. Murali, D.T. Golenbock, and A.D. Luster Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9 J Clin Invest 115 2005 407 417
77. M.W. Boule, C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I.R. Rifkin Toll-like receptor 9-dependent and-independent dendritic cell activation by chromatin-immunoglobulin G complexes J Exp Med 199 2004 1631 1640
78. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H. Wang, B. Homey, W. Cao, Y.H. Wang, B. Su, F.O. Nestle, T. Zal, I. Mellman, J.M. Schroder, Y.J. Liu, and M. Gilliet Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 449 2007 564 569
79. C. Vancheri, M. Failla, N. Crimi, and G. Raghu Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Eur Respir J 35 2010 496 504
80. K. Takahashi, Y. Sugi, A. Hosono, and S. Kaminogawa Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis J Immunol 183 2009 6522 6529